GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CAS Medical Systems Inc (NAS:CASM) » Definitions » Median PS Value

CAS Medical Systems (CAS Medical Systems) Median PS Value : $0.00 (As of May. 11, 2024)


View and export this data going back to 1995. Start your Free Trial

What is CAS Medical Systems Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. CAS Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2018 was $0.789. CAS Medical Systems's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-05-11), CAS Medical Systems's share price is $2.45. CAS Medical Systems's Median PS Value is $0.00. Therefore, CAS Medical Systems's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for CAS Medical Systems's Median PS Value or its related term are showing as below:

CASM's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.82
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

CAS Medical Systems Median PS Value Historical Data

The historical data trend for CAS Medical Systems's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CAS Medical Systems Median PS Value Chart

CAS Medical Systems Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CAS Medical Systems Quarterly Data
Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CAS Medical Systems's Median PS Value

For the Medical Instruments & Supplies subindustry, CAS Medical Systems's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CAS Medical Systems's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CAS Medical Systems's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where CAS Medical Systems's Price-to-Median-PS-Value falls into.



CAS Medical Systems Median PS Value Calculation

CAS Medical Systems's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.789*0
=0.00

10-Year Median PS Ratio is 0.
CAS Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.789.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CAS Medical Systems  (NAS:CASM) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

CAS Medical Systems's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=2.45/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CAS Medical Systems Median PS Value Related Terms

Thank you for viewing the detailed overview of CAS Medical Systems's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CAS Medical Systems (CAS Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
44 East Industrial Road, Branford, CT, USA, 06405
CAS Medical Systems Inc is a medical technology company that develops, manufactures, and markets non-invasive patient monitoring products. The company's products are the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. .
Executives
Alan Milinazzo director C/O ORTHOFIX INC, 10115 KINCEY AVENUE STE 250, HUNTERSVILLE NC 28078
Thomas M Patton director, officer: President and CEO C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Kenneth R Weisshaar director 875 PARK AVE APT 2D, NEW YORK NY 10021
James E Thomas director, 10 percent owner WOODS END ROAD, NEW CANAAN CT 06840
Thomas, Mcnerney & Partners Ii L.p. 10 percent owner 45 SOUTH 7TH STREET, SUITE 3060, Minneapolis MN 55402
Tmp Associates Ii Lp 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Tmp Nominee Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Thomas, Mcnerney & Partners Ii, Llc 10 percent owner 45 SOUTH SEVENTH STREET, SUITE 3060, MINNEAPOLIS MN 55402
Acuta Capital Fund, Lp 10 percent owner 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations International Master Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Lawrence Burstein director C/O UNITY VENTURE CAPITAL ASSOCIATES LTD, 245 FIFTH AVENUE, SUITE 1500, NEW YORK NY 10016